MorphoSys Analyst Ratings
BenzingaMar 14 16:04 ET
Morphosys Ag (MOR) Receives a Hold From JMP Securities
TipRanksMar 14 11:05 ET
JMP Cuts Incyte to Market Perform, Cites Need for Acquisition
Seeking AlphaFeb 14 15:20 ET
JMP Securities Downgrades Morphosys Ag (MOR) to a Hold
TipRanksFeb 6 13:46 ET
MorphoSys Analyst Ratings
BenzingaFeb 5 14:12 ET
Analysts Conflicted on These Healthcare Names: Cencora (COR) and Morphosys Ag (MOR)
TipRanksFeb 5 13:20 ET
MorphoSys Analyst Ratings
BenzingaJan 19 05:37 ET
MorphoSys Analyst Ratings
BenzingaJan 16 06:35 ET
MorphoSys Analyst Ratings
BenzingaDec 15, 2023 12:33 ET
MorphoSys Analyst Ratings
BenzingaDec 5, 2023 10:51 ET
JPMorgan Trims MorphoSys Price Target to $8.50 From $10, Maintains Overweight Rating
MT NewswiresDec 5, 2023 08:09 ET
Analysts' Top Healthcare Picks: Morphosys Ag (MOR), Abbott Labs (ABT)
TipRanksNov 22, 2023 07:40 ET
MorphoSys Analyst Ratings
BenzingaNov 21, 2023 10:53 ET
Analysts Offer Insights on Healthcare Companies: Morphosys Ag (MOR) and Enanta Pharmaceuticals (ENTA)
TipRanksNov 21, 2023 00:31 ET
Analysts Offer Insights on Healthcare Companies: Arcturus Therapeutics (ARCT), DENTSPLY SIRONA (XRAY) and Morphosys Ag (MOR)
TipRanksNov 6, 2023 06:00 ET
Morgan Stanley Upgrades MorphoSys to Overweight, Raises Price Target to $9.2
BenzingaOct 13, 2023 06:09 ET
MorphoSys Analyst Ratings
BenzingaOct 13, 2023 06:06 ET
Goldman Sachs Upgrades MorphoSys to Neutral, Raises Price Target to $9.25
BenzingaSep 15, 2023 04:11 ET
MorphoSys Analyst Ratings
BenzingaSep 15, 2023 04:10 ET
JMP Securities Remains a Buy on Morphosys Ag (MOR)
TipRanksAug 10, 2023 14:25 ET
No Data
No Data